Q1 2021 13F Holders as of 3/31/2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
44.7M
-
Number of holders
-
85
-
Total 13F shares, excl. options
-
26.4M
-
Shares change
-
+539K
-
Total reported value, excl. options
-
$144M
-
Value change
-
+$3.18M
-
Number of buys
-
40
-
Number of sells
-
-39
-
Price
-
$5.46
Significant Holders of HARVARD BIOSCIENCE INC - Common Stock (HBIO) as of Q1 2021
93 filings reported holding HBIO - HARVARD BIOSCIENCE INC - Common Stock as of Q1 2021.
HARVARD BIOSCIENCE INC - Common Stock (HBIO) has 85 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 26.4M shares
of 44.7M outstanding shares and own 59.08% of the company stock.
Largest 10 shareholders include BlackRock Inc. (2.97M shares), DIMENSIONAL FUND ADVISORS LP (1.97M shares), ROYCE & ASSOCIATES LP (1.92M shares), PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. (1.71M shares), Portolan Capital Management, LLC (1.61M shares), VANGUARD GROUP INC (1.52M shares), GRANAHAN INVESTMENT MANAGEMENT INC/MA (1.52M shares), RENAISSANCE TECHNOLOGIES LLC (1.43M shares), Harvey Partners, LLC (1.1M shares), and ACADIAN ASSET MANAGEMENT LLC (1.02M shares).
This table shows the top 85 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.